Summary by Moomoo AI
RedHill Biopharma Ltd., a biopharmaceutical company, has received a Notice of Effectiveness from the United States Securities and Exchange Commission (SEC) on April 22, 2024. The notice indicates that the company's submission, identified by Accession Number 0001558370-24-005273 and Submission Type POS AM, has been officially accepted by the SEC. The effectiveness of the submission is a significant regulatory milestone for RedHill Biopharma, which is listed under CIK number 0001553846 and file number 333-276979.